Neurophos has filed a notice of an exempt offering of securities to raise $109,171,214.00 in New Funding.
According to filings with the U.S. Securities and Exchange Commission, Neurophos is raising up to $109,171,214.00 in new funding. The federal securities law requires the notice to be filed by companies that have sold securities without registration under the Securities Act of 1933 in an offering made under Rule 504 or 506 of Regulation D or Section 4(a)(5) of the Securities Act. A company must file this notice within 15 days after the first sale of securities in the offering. For this purpose, the date of first sale is the date on which the first investor is irrevocably contractually committed to invest. Each issuer of securities that sells its securities in reliance on an exemption provided in Regulation D or Section 4(a)(5) of the Securities Act of 1933 must file this notice containing the information requested with the U.S. Securities and Exchange Commission (SEC) and with the state(s) requiring it. If more than one issuer has sold its securities in the same transaction, all issuers should be identified in this filing with the SEC.
About Neurophos
Neurophos makes the OPU, a photonic AI chip that delivers the performance of a 3,000-pound server in the size and power envelope of a single GPU. Neurophos novel optical transistor unlocks terawatt-scale compute at a gigawatt-scale footprint, fitting millions of weights in the area of a postage stamp, that would otherwise occupy a full square-meter.
To learn more about Neurophos, visit https://www.neurophos.com/
Neurophos Linkedin Page: https://www.linkedin.com/company/neurophos/
Contact:
Patrick Bowen, Chief Executive Officer
737-367-5551
https://www.linkedin.com/in/ptbowen/
SOURCE: http://www.intelligence360.io
Copyright (c) 2026 SI360 Inc. All rights reserved.
